Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 31,919 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke. DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
The authors of a study published in Alzheimer Disease and Associated Disorders
found that elderly individuals using antidepressants were at
significantly higher risk for dementia when compared with both depressed
and not depressed nonusers. The study, which is one of the few
long-term studies focusing on associations between antidepressants and
dementia, followed a large group of participants for up to 18 years.
“In this elderly primary care patient cohort, we found
that SSRIs users were at significantly higher risk for incident dementia
when compared with not depressed nonusers and also when compared with
nonusers with depression. Patients who were taking non-SSRIs also showed
significantly higher risk for incident dementia when compared with
nonusers without depression.”
Antidepressants, including selective serotonin re-uptake inhibitors
(SSRI), are commonly prescribed drugs in the U.S. Despite studies that
have suggested these could have neuroprotective effects and that they can improve cognitive function
in patients with Alzheimer’s dementia, these results are not
consistent. Studies conducted with different populations have also found
conflicting results with some finding that older antidepressants were
associated with a reduced rate of dementia and others have found antidepressant use associated with cognitive impairment. Further, as the authors, led by Dr. Chenkun Wang, point out, elderly individuals are often underrepresented in clinical trials,
therefore little is known about this antidepressant use in this
population, particularly those with unimpaired cognitive functioning.
Over a span of two years (i.e. 1991-1993) 3,688 patients from a
private care practice were enrolled in the study and included in the
analysis – all of whom were 60 years of age or older. The researchers
used medical history information from inpatient, outpatient, and
emergency room records. Among the data retrieved were diagnoses of
depression and dementia. Data regarding their antidepressant medication
prescription and dispersal was also retrieved from their electronic
medical record. Patients were divided into 5 groups:
Participants diagnosed with depression but not prescribed antidepressants (nonusers with depression)
Participants diagnosed who were not diagnosed with depression nor received antidepressants (nonusers without depression)
Results revealed that participants who were on SSRIs or non-SSRI
antidepressants had a higher risk of dementia than the individuals
diagnosed with depression who were not prescribed antidepressants. In
addition, those who were on either type of antidepressant were at a
higher risk of dementia than nonusers without depression.
Despite the limitations of the study, which include prescribing bias
(e.g. doctors prescribing SSRIs to adults with cognitive impairments)
and lack of depression and dementia severity measures, this is not the
only study to yield these associations. A recent article on Medscape
reporting on SSRIs and sleep disruption found that these
antidepressants could cause significant sleep problems in the elderly,
which could contribute to neurodegeneration leading to dementia. The
authors of the study, which was presented at the Institute of
Psychiatric Services: The Mental Health Services 2016 Conference, warn
against ignoring sleep issues and side-effects of SSRIs and reiterate
the importance of psychotherapy and holistic alternatives for elderly
populations.
****
Wang, C., Gao, S., Hendrie, H. C., Kesterson, J., Campbell, N. L.,
Shekhar, A., & Callahan, C. M. (2016). Antidepressant use in the
elderly is associated with an increased risk of dementia. Alzheimer Disease & Associated Disorders, 30(2), 99-104. (Abstract)
No comments:
Post a Comment